| 07 Mar 2010 |
|
International experts gather to discuss innovations in infertility management
- Text size
Dubai, UAE - International experts gathered to talk about growing infertility rates in UAE and discuss new advancements in medicinal treatment of infertility, during a two day seminar in Dubai and Abu Dhabi. The gathering focused on growing infertility rates, both regionally and globally, and new advancements and techniques in the management of infertility, including the tailoring of patient treatment. The seminars also reviewed data and meta-analysis concerning efficiency and safety of recombinant over urine-based products for infertility treatment.
Professor Pasquale Patrizio, Professor of Obstetrics and Gynaecology at the Yale School of Medicine commented that "It is imperative to convey the message that fertility decreases after the age of 35, and becomes a serious problem after the age of 37. The concept of waiting one year of unprotected intercourse before seeking treatment is not applicable to everyone: women older than 37 should be seen after 6 months of unprotected intercourse otherwise there is a risk of losing precious time. The problem is that nobody talks about this issue, and it is important that awareness is raised in UAE as we are doing in other parts of the world. It is therefore essential that increased awareness is raised and that both men and women become educated and knowledgeable on the topic so that they can make the best informed decisions"
Professor Pasquale who is visiting UAE for the 2 day seminar in Dubai and Abu Dhabi continued, "Many women are unaware of the many options they have when choosing an infertility treatment. For one, Poly Cystic Ovarian Syndrome (known as PCOS) is a common disorder that reduces fertility amongst women. This disease is characterized by irregular menstrual cycles, as well as an excess of androgens that can cause abnormal growth of body hair and oily skin. This syndrome is commonly associated with obesity, making it a very real problem within the UAE. Statistics reveal that, despite equally high rates of obesity in the US, within the UAE the incidence of PCOS cases is double compared to US. .
"It is to be well-noted that PCOS is not only an infertility disease. It is also a condition that may cause diabetes and high lipids profiles characteristic of a true metabolic disorder.
When patients suffering from PCOS decide to take action through infertility treatment, it is very important that they will seek advice from professionals experienced in both the metabolic disorders and in the use of correct dosages of fertility medications so to avoid risky side effects". Many times women with PCOS and with other types of infertility are treated with In vitro fertilisation (IVF).
IVF is therapy based on the use of gonadotrophins to stimulate the ovaries to produce more eggs. Eggs are then retrieved and fertilised in vitro with the partner's sperm. After fertilisation one or more embryos (depending on the age of the patient, the etiology of infertility and the quality of the embryos) are transferred to the uterus.
-Ends-
© Press Release 2010
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.